Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
134 Cards in this Set
- Front
- Back
|
Cimetidine
|
H2 Receptor Antagonist
|
|
|
Ranitidine
|
H2 Receptor Antagonist
|
|
|
Omeprazole
|
Proton Pump Inhibitor
|
|
|
Pirenzepine
|
Muscarinic M1 Antagonist
(The Original Anti-Ulcer Drug) (Not used anymore due to side effects) |
|
|
Aluminium Hydroxide
|
Antacid
|
|
|
Magnesium Hydroxide
|
Antacid
|
|
|
Sodium Bicarbonate
|
Antacid
|
|
|
Sucralfate
|
Mucosal Protectant
|
|
|
Colloidal Bismuth
|
Mucosal Protectant
|
|
|
Misoprostol
|
Synthetic Prostaglandin E1 |
|
|
Indomethacin
|
Cyclooxygenase Inhibitor
|
|
|
Ibuprophen
|
Cyclooxygenase Inhibitor
|
|
|
Colchicine
|
Microtubule Assembly Inhibitor
|
|
|
Allopurinol
|
Competitive Xanthine Oxidase Inhibitor
|
|
|
Probenecid
|
Uricosuric Agent
|
|
|
Sulphinpyrazone
|
Uricosuric Agent
|
|
|
Uricase
|
Uric Acid Metabolizer
|
|
|
Hydroxychloroquine
|
Disease Modifying Antirheumatic Drug (DMARD)
|
|
|
Sulphasalazine
|
Disease Modifying Antirheumatic Drug (DMARD)
|
|
|
Sodium Aurothiomalate
|
Gold Salt
Macrophage Suppression |
|
|
Aurofin
|
Gold Salt
Macrophage Suppression |
|
|
Penicillamine
|
Chelates Heavy Metals
|
|
|
Methotraxate
|
Folic Acid Antagonist
|
|
|
Leflunomide
|
Dihydroorotate Dehydrogenase Inhibitor
|
|
|
Azathioprine
|
Purine Analogue Cytotoxic to Inflammatory Cells
|
|
|
Cyclosporine
|
Antibiotic
|
|
|
Salbutamol
|
Beta 2 Agonist
|
|
|
Adrenaline
|
Non-Selective Adrenergic Agonist
|
|
|
Isoprenaline
|
Non-Selective Adrenergic Agonist
|
|
|
Theophylline
|
Phosphodiesterase Inhibitor
Xanthine Class |
|
|
Ipratropium
|
Non-Selective Muscarinic Receptor Antagonist
|
|
|
Cromoglycate
|
Prophylactic Agent for Asthmatics
|
|
|
Beclomethasone
|
Glucocorticoid
|
|
|
Zileuton
|
5-Lipoxygenase Inhibitor
|
|
|
Zafirlukast
|
cysLT1 Receptor Antagonist
|
|
|
Montelukast
|
cysLT1 Receptor Antagonist
|
|
|
Nifedipine (Inhaled)
|
Calcium Channel Blocker
|
|
|
Verapamil (Inhaled)
|
Calcium Channel Blocker
|
|
|
Chromakalim
|
Potassium Channel Openers
|
|
|
Omalizumab
|
Anti-IgE Monoclonal Antibodies
|
|
|
Tropicamide
|
Muscarinic Antagonist
|
|
|
Timolol
|
Beta Receptor Antagonist
|
|
|
Dorzolamide
|
Carbonic Anhydrase Inhibitor
|
|
|
Pilocarpine
|
Muscarinic Agonist
|
|
|
Lanaprost
|
Prostaglandin F2 alpha Analogue
|
|
|
Verteprofin
|
Photodynamic Therapy Agent
|
|
|
Ranibizumab
|
VEGF Monoclonal Antibodies
|
|
|
Metronidazole
|
Prodrug of Cytotoxic, Antibiotic Compound
Clinically Used to Kill Amoeba and Anaerobic Organisms |
|
|
Pentamidine
|
DHFR Inhibitor
Clinicallyused to treat Early Stage (non-CNS) in Trypanosomiasis (Sleeping Sickness) |
|
|
Suramin
|
Multi-Enzyme Inhibitor
Clinicallyused to treat Early Stage (non-CNS) in Trypanosomiasis (Sleeping Sickness) |
|
|
Melarsopol
|
Combination of Dimercaptopropanol and Melarsen Oxide (Arsenic Compound)
Clinicallyused to treat Late Stage (CNS) in Trypanosomiasis (Sleeping Sickness) |
|
|
Sodium Stibogluconate
|
Anti-Protazoal Agent
|
|
|
Meglumine Antimonate
|
Anit-Protazoal Agent
|
|
|
Miltefosine
|
Anti-Protazoal Agent
Synthetic Ether Phospholipid Analogue |
|
|
Ivermectin
|
Semisynthetic Macrocyclic Lactone
Clinically used against many Helminths and Arthropods |
|
|
Piperazine
|
GABA Receptor Agonist
Clinically used (historically) to treat Round Worm and Pin Worm |
|
|
Pyrantel Pamoate
|
Cation Channel Agonist
Depolarizing Neuromuscular Blocking Agent Clinically Used as Third Line Agent against Hookworm, Pinworm, or Roundworm Infections |
|
|
Albendazole
|
Microtubule Assembly Inhibitor
Anti-Helminthic Agent |
|
|
Mebendazole
|
Microtuble Assembly Inhibitor
Anti-Helminthic Agent |
|
|
Praziquantel
|
Anti-Helminthic Agent
|
|
|
Diethylcarbamizine (DEC)
|
Piperazine Derivative
Anti-Helminthic Agent |
|
|
Erlotinib
|
EGFR Inhibitor
Anti-Cancer Agent |
|
|
Cetuximab
|
Chimeric Mouse/Human IgG1 Monoclonal Antibody to EGFR (ErbB1)
Anti-Cancer Agent |
|
|
Trastuzumab
|
Chimeric Mouse/Human IgG1 Monoclonal Antibody to EGFR (ErbB2)
Anti-Cancer Agent |
|
|
Imatinib Mesylate
|
Tyrosine Kinase Inhibitor
Anti-Cancer Agent |
|
|
Tipifarnib
|
Farnesyltransferase Inhibitor
Clinically used for Relapsed/Refractory AML |
|
|
Sorafenib
|
Multiple rTK Inhibitor (VEGFR-1, VEGFR-2, PDGFR, and B-RAF Kinase)
Anti-Cancer Agent |
|
|
Bortezomib
|
Proteasome Inhibitor
Anti-Cancer Agent |
|
|
Bevacizumab
|
Humanised Mouse IgG1 Antibody against VEGF-A
Anti-Cancer Agent |
|
|
Vatalanib
|
VEGFR-1 and VEGFR-2 Inhibitor
|
|
|
Rituximab
|
Anti-CD20 Antibody
Targets B Cell Non-Hodgkin's Lymphoma |
|
|
Alemtuzumab
|
Anti-CD52 Antibody
Targets Chronic Lymphocytic Leukaemia |
|
|
Gemtuzumab
|
Anti-CD33 Antibody Conjugated to Calicheamicin
Targets Acute Myeloid Leukaemia |
|
|
Enfuvirtide
|
Anti-HIV Peptide
Fusion Inhibitor Anti-HIV Drrug |
|
|
Amantadine
|
Ion Channel Inhibitor
Anti-Influenza A Drug |
|
|
Rimantadine
|
Ion Channel Inhibitor
Anti-Influenza A Drug |
|
|
Raltegravir
|
HIV Integrase Inhibitor
Anti-HIV Drug |
|
|
Zidovudine (AZT)
|
Thymidine Analogue
Nucleoside Reverse Transcriptase Inhibitor (NRTI) Anti-HIV Drug |
|
|
Lamivudine (3TC)
|
Cytidine Analogue
Nucleoside Reverse Transciptase Inhibitor (NRTI) Anti-HIV Drug |
|
|
Acyclovir
|
Guanine Base Attached to Incomplete Sugar
Anti-HSV/VCZ Drug |
|
|
Efavirenz
|
Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Anti-HIV Drug |
|
|
Nevirapine
|
Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Anti-HIV Drug |
|
|
Ritonavir
|
HIV Protease Inhibitor
Anti-HIV Drug |
|
|
Saquinavir
|
HIV Protease Inhibitor
Anti-HIV Drug |
|
|
Zanamivir
|
Sialic Acid Analogue
Anti-Influenza Drug |
|
|
Oseltamivir
|
Prodrug Sialic Acid Analogue
Anti-Influenza Drug |
|
|
Ketoconazole
|
CYP450 Enzyme Inhibitor (specifically ones involved with production of Cortisol and Aldosterone) |
|
|
Metyrapone
|
Reversible 11 beta - Hyroxylase Inhibitor
|
|
|
Hydrocortisone (Cortisol)
|
Endogenous Glucocorticoid
|
|
|
Cortisone
|
Pro-Drug Version of Glucocorticoid
|
|
|
Prednisone
|
Pro-Drug Version of Glucocorticoid
|
|
|
Prednisolone
|
Synthetic Glucocorticoid
|
|
|
Dexamethasone
|
Synthetic Glucocorticoid
|
|
|
Fluticasone
|
Synthetic Glucocorticoid
|
|
|
Beclomethasone
|
Synthetic Glucocorticoid
|
|
|
Methylprednisolone
|
Synthetic Cortisol Analogue
|
|
|
Fludrocortisone
|
Synthetic Cortisol Analogue with High Mineralocorticoid Activity
|
|
|
Spironolactone
|
Competative Aldosterone Receptor Antagonist
Potassium Sparing Diuretic |
|
|
Eplerenone
|
Competitve Aldosterone Receptor Antagonist
Potassium Sparing Diuretic |
|
|
Simvastatin
|
HMG-CoA Reductase Inhibitor
(Reversible and Competitive) Short Acting Statin |
|
|
Lovastatin
|
HMG-CoA Reductase Inhibitor
(Reversible and Competitive) Short Acting Statin |
|
|
Pravastatin
|
HMG-CoA Reductase Inhibitor
(Reversible and Competitive) Short Acting Statin |
|
|
Atorvastatin
|
HMG-CoA Reductase Inhibitor
(Reversible and Competitive) Long Acting Statin |
|
|
Rosuvastatin
|
HMG-CoA Reductase Inhibitor
(Reversible and Competitive) Long Acting Statin |
|
|
Gemfibrozil
|
Peroxisome Proliferator Activated Receptor Alpha (PPAR-alpha) Agonist
Fibrate Lipid Lowering Agent |
|
|
Fenofibrate
|
Peroxisome Proliferator Activated Receptor Alpha (PPAR-alpha) Agonist
Fibrate Lipid Lowering Agent |
|
|
Ciprofibrate
|
Peroxisome Proliferator Activated Receptor Alpha (PPAR-alpha) Agonist
Fibrate Lipid Lower Agent |
|
|
Colestyramine
|
Bile Acid-Binding Resin
Lipid Lowering Agent |
|
|
Colestipol
|
Bile Acid-Binding Resin
Lipid Lowering Agent |
|
|
Ezetimibe
|
Niemann-Pick C1-like 1 (NCPC1L1) Cholesterol Transport Protein Inhibitor
Cholesterol Absorption Inhibitor |
|
|
Niacin
|
Nicotinic Acid (Vitamin B3)
Lipid Lowering Agent |
|
|
Omacor
|
Polyunsaturated Fatty Acids
(Ex. Eicosapentaenoic and Docosahexaenoic Acid) Fish Oil Derivative Lipid Lowering Agent |
|
|
Aspirin
|
Irreversible Cyclooxygenase Inhibitor
First Line Anti-Platelet Agent |
|
|
Clopidogrel
|
Irreversible ADP Receptor Inhibitor
Second Line Anti-Platelet Agent (or combo with Aspirin) |
|
|
Prasugrel
|
Irreversible ADP Receptor Inhibitor
Anti-Platelet Agent |
|
|
Dipyridamole
|
Phosphodiesterase Inhibitor
Anti-Platelet Agent (relatively weak) |
|
|
Abciximab
|
Irreversible GPIIb-IIIa Antagonist (monoclonal antibody)
Anti-Platelet Agent |
|
|
Eptifibatide
|
GPIIb-IIIa Antagonist
|
|
|
Tirofiban
|
GPIIb-IIIa Antagonist
|
|
|
Heparin (unfractionated)
|
Thrombin and Factor Xa Inhibitor
Anti-Coagulant |
|
|
Dalteparin
|
Factor Xa Inhibitor
Anti-Coagulant Heparin (low molecular weight) |
|
|
Enoxaparin
|
Factor Xa Inhibitor
Anti-Coagulant Heparin (low molecular weight) |
|
|
Lepirudin
|
Direct Thrombin Inhibitor
|
|
|
Warfarin
|
Competitive Vitamin K Epoxide Reductase Component 1 (VKORC1) Inhibitor
Anti-Coagulant |
|
|
Dabigatran
|
Direct Thrombin Inhibitor
|
|
|
Rivaroxaban
|
Factor Xa Inhibitor
|
|
|
Protamine Sulphate
|
Heparin Antidote
|
|
|
Streptokinase
|
Plasminogen Activator
Fibrinolysis/Thrombolytic Agent |
|
|
Alteplase
|
Recombinant Tissue Plasminogen Activator (t-PA)
Fibrinolysis/Thrombolytic Agent |
|
|
Tranexamic Acid
|
Lysine Analogue
Plasminogen Activation Inhibitor Anti-Fibrinolytic Drugs |
|
|
Aminocaproic Acid
|
Lysine Analogue
Plasminogen Activation Inhibitor Anti-Fibrinolytic Drugs |
|
|
Desmopressin
|
Synthetic ADH Analogue
Anti-Fibrinolytic Drugs |
|
|
Etamyslate
|
Synthetic Haemostasis Drug
Indicated for short-term blood loss in menorrhagia |
|
|
Eptacog Alfa
|
Recombinant Factor VIIa
|
